Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Biomarin Pharmaceutical Inc (BMRN)
since 2005 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Biomarin Pharmaceutical Inc.
(See page 1 of this report.) Table 2 shows the detailed insider transactions.
This company's CIK number is 1048477.
Total stock buying since 2005: $2,433,737.
Total stock sales since 2005: $583,535,292.
Total stock option exercises since 2005: $188,288,866.
Table 3. Detailed insider trading at Biomarin Pharmaceutical Inc (BMRN) , Part 11
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2007-10-01 | Davis George Eric (VP, General Counsel) | Option Ex | 5,000 | 6.13 | 30,650 |
| 2007-10-01 | Swiedler Stuart J (SVP, Clinical Affairs) | Sale | 12,500 | 25.07 | 313,400 |
| 2007-10-01 | Swiedler Stuart J (SVP, Clinical Affairs) | Option Ex | 12,500 | 5.07 | 63,312 |
| 2007-10-01 | Aselage Steve (SVP, Global Commercial Dev) | Sale | 5,000 | 25.09 | 125,450 |
| 2007-10-01 | Aselage Steve (SVP, Global Commercial Dev) | Option Ex | 5,000 | 7.16 | 35,800 |
| 2007-10-01 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 793 | 25.10 | 19,904 |
| 2007-10-01 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 793 | 6.46 | 5,122 |
| 2007-09-28 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 19,207 | 25.00 | 480,175 |
| 2007-09-28 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 19,207 | 6.46 | 124,077 |
| 2007-09-26 | Cooper Jeffrey H (SVP, Chief Financial Officer) | Sale | 12,500 | 24.50 | 306,250 |
| 2007-09-26 | Cooper Jeffrey H (SVP, Chief Financial Officer) | Option Ex | 12,500 | 8.10 | 101,250 |
| 2007-09-25 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 10,000 | 24.00 | 240,000 |
| 2007-09-25 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 10,000 | 6.46 | 64,600 |
| 2007-09-21 | Wood Mark (VP, Human Resources) | Sale | 5,906 | 23.24 | 137,261 |
| 2007-09-21 | Wood Mark (VP, Human Resources) | Option Ex | 5,906 | 9.56 | 56,461 |
| 2007-09-19 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 10,000 | 23.00 | 230,000 |
| 2007-09-19 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 10,000 | 6.46 | 64,600 |
| 2007-09-14 | Baffi Robert (SVP, Technical Operations) | Sale | 90,000 | 22.57 | 2,026,593 |
| 2007-09-14 | Baffi Robert (SVP, Technical Operations) | Option Ex | 90,000 | 6.13 | 551,700 |
| 2007-09-14 | Aselage Steve (SVP, Global Commercial Dev.) | Sale | 10,000 | 22.40 | 224,000 |
| 2007-09-14 | Aselage Steve (SVP, Global Commercial Dev.) | Option Ex | 10,000 | 7.16 | 71,600 |
| 2007-09-06 | Cooper Jeffrey H (SVP, Chief Financial Officer) | Sale | 13,536 | 22.50 | 304,560 |
| 2007-09-06 | Cooper Jeffrey H (SVP, Chief Financial Officer) | Option Ex | 13,536 | 8.10 | 109,641 |
| 2007-08-17 | Cooper Jeffrey H (SVP, Chief Financial Officer) | Sale | 20,000 | 20.28 | 405,640 |
| 2007-08-17 | Cooper Jeffrey H (SVP, Chief Financial Officer) | Option Ex | 20,000 | 6.35 | 126,920 |
| 2007-08-17 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 10,000 | 21.00 | 210,000 |
| 2007-08-17 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 10,000 | 6.46 | 64,600 |
| 2007-08-15 | Davis George Eric (VP, General Counsel) | Sale | 4,000 | 20.26 | 81,040 |
| 2007-08-15 | Davis George Eric (VP, General Counsel) | Option Ex | 4,000 | 6.13 | 24,520 |
| 2007-08-10 | Wood Mark (VP, Human Resources) | Sale | 2,633 | 21.08 | 55,503 |
| 2007-08-10 | Wood Mark (VP, Human Resources) | Option Ex | 2,633 | 8.08 | 21,274 |
| 2007-08-10 | Aselage Steve (SVP, Global Commercial Dev) | Sale | 20,000 | 20.29 | 405,880 |
| 2007-08-10 | Aselage Steve (SVP, Global Commercial Dev) | Option Ex | 20,000 | 7.16 | 143,200 |
| 2007-08-10 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 35,886 | 20.20 | 725,076 |
| 2007-08-10 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 35,886 | 6.46 | 231,823 |
| 2007-08-10 | Lewis Alan (Director) | Sale | 20,000 | 20.13 | 402,680 |
| 2007-08-10 | Lewis Alan (Director) | Option Ex | 30,000 | 7.72 | 231,600 |
| 2007-08-08 | Cooper Jeffrey H (SVP, Chief Financial Officer) | Sale | 12,500 | 21.00 | 262,500 |
| 2007-08-08 | Cooper Jeffrey H (SVP, Chief Financial Officer) | Option Ex | 12,500 | 8.10 | 101,250 |
| 2007-08-03 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 2,000 | 18.02 | 36,048 |
| 2007-07-05 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 2,000 | 18.28 | 36,568 |
| 2007-07-02 | Swiedler Stuart J (SVP, Clinical Affairs) | Sale | 12,500 | 18.18 | 227,250 |
| 2007-07-02 | Swiedler Stuart J (SVP, Clinical Affairs) | Option Ex | 12,500 | 4.00 | 50,000 |
| 2007-06-25 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 2,500 | 17.65 | 44,125 |
| 2007-06-07 | Wood Mark (VP, Human Resources) | Sale | 1,045 | 17.54 | 18,332 |
| 2007-06-07 | Wood Mark (VP, Human Resources) | Option Ex | 1,045 | 8.08 | 8,443 |
| 2007-06-04 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 2,500 | 18.39 | 45,975 |
| 2007-06-01 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 10,000 | 18.33 | 183,299 |
| 2007-06-01 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 10,000 | 6.46 | 64,600 |
| 2007-05-21 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 2,000 | 18.56 | 37,120 |
| 2007-05-03 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 15,000 | 16.79 | 251,790 |
| 2007-05-03 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 15,000 | 6.46 | 96,900 |
| 2007-05-02 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 1,500 | 16.43 | 24,646 |
| 2007-04-30 | Davis George Eric (VP, General Counsel) | Buy | 2,607 | 5.18 | 13,517 |
| 2007-04-30 | Baffi Robert (SVP, Technical Operations) | Buy | 2,684 | 5.18 | 13,916 |
| 2007-04-30 | Kakkis Emil D (Chief Medical Officer) | Buy | 2,982 | 5.18 | 15,461 |
| 2007-04-30 | Aselage Steve (SVP, Global Commercial Dev) | Buy | 2,066 | 6.92 | 14,294 |
| 2007-04-30 | Bienaime Jean Jacques (Chief Executive Officer) | Buy | 2,553 | 6.92 | 17,664 |
| 2007-04-04 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 6,500 | 17.86 | 116,116 |
| 2007-04-04 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 5,000 | 6.46 | 32,300 |
| 2007-04-02 | Swiedler Stuart J (SVP, Clinical Affairs) | Sale | 12,500 | 17.30 | 216,237 |
| 2007-04-02 | Swiedler Stuart J (SVP, Clinical Affairs) | Option Ex | 12,500 | 4.00 | 50,000 |
| 2007-03-07 | Klein Joseph Iii (Director) | Sale | 12,000 | 16.37 | 196,464 |
| 2007-03-02 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 1,500 | 16.48 | 24,724 |
| 2007-02-22 | Davis George Eric (VP, General Counsel) | Sale | 13,000 | 18.38 | 238,940 |
| 2007-02-22 | Davis George Eric (VP, General Counsel) | Option Ex | 13,000 | 6.13 | 79,690 |
| 2007-02-22 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 1,000 | 18.40 | 18,400 |
| 2007-02-20 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 13,000 | 16.96 | 220,480 |
| 2007-02-14 | Aselage Steve (SVP, Global Commercial Ops) | Sale | 15,000 | 20.00 | 300,000 |
| 2007-02-14 | Aselage Steve (SVP, Global Commercial Ops) | Option Ex | 15,000 | 7.16 | 107,400 |
| 2007-01-03 | Swiedler Stuart J (SVP, Clinical Affairs) | Sale | 12,500 | 16.30 | 203,700 |
| 2007-01-03 | Swiedler Stuart J (SVP, Clinical Affairs) | Option Ex | 12,500 | 4.00 | 50,000 |
| 2006-12-12 | Lapalme Pierre (Director) | Buy | 2,100 | 17.88 | 37,554 |
| 2006-12-06 | Cooper Jeffrey H (Chief Financial Officer) | Sale | 14,500 | 18.00 | 261,000 |
| 2006-12-06 | Cooper Jeffrey H (Chief Financial Officer) | Option Ex | 14,500 | 8.10 | 117,450 |
| 2006-11-29 | Aselage Steve (SVP, Global Commercial Ops) | Sale | 5,000 | 17.23 | 86,150 |
| 2006-11-29 | Aselage Steve (SVP, Global Commercial Ops) | Option Ex | 5,000 | 7.16 | 35,800 |
| 2006-11-01 | Swiedler Stuart J (SVP, Clinical Affairs) | Sale | 12,500 | 15.92 | 198,975 |
| 2006-11-01 | Swiedler Stuart J (SVP, Clinical Affairs) | Option Ex | 12,500 | 4.00 | 50,000 |
| 2006-10-31 | Baffi Robert (SVP, Technical Operations) | Buy | 3,894 | 3.43 | 13,371 |
| 2006-10-31 | Kakkis Emil D (Chief Medical Officer) | Buy | 4,368 | 3.43 | 14,999 |
| 2006-10-31 | Aselage Steve (SVP, Global Commercial Ops) | Buy | 1,870 | 6.92 | 12,938 |
| 2006-10-31 | Bienaime Jean Jacques (Chief Executive Officer) | Buy | 2,761 | 6.92 | 19,103 |
| 2006-08-29 | Cooper Jeffrey H (VP, Chief Financial Officer) | Sale | 26,000 | 16.00 | 416,000 |
| 2006-08-29 | Cooper Jeffrey H (VP, Chief Financial Officer) | Option Ex | 26,000 | 7.12 | 184,990 |
| 2006-08-09 | Klein Joseph Iii (Director) | Sale | 40,000 | 15.52 | 620,640 |
| 2006-08-09 | Klein Joseph Iii (Director) | Option Ex | 60,000 | 7.72 | 463,200 |
| 2006-08-07 | Lapalme Pierre (Director) | Buy | 1,000 | 15.35 | 15,350 |
| 2006-08-01 | Swiedler Stuart J (SVP, Clinical Affairs) | Sale | 12,500 | 14.34 | 179,187 |
| 2006-08-01 | Swiedler Stuart J (SVP, Clinical Affairs) | Option Ex | 12,500 | 4.00 | 50,000 |
| 2006-08-01 | Bienaime Jean Jacques (Chief Executive Officer) | Buy | 1,500 | 14.50 | 21,750 |
| 2006-07-19 | Heron Elaine J (Director) | Option Ex | 20,000 | 4.72 | 94,400 |
| 2006-07-03 | Bienaime Jean Jacques (Chief Executive Officer) | Buy | 1,500 | 14.44 | 21,658 |
| 2006-06-01 | Bienaime Jean Jacques (Chief Executive Officer) | Buy | 1,500 | 13.05 | 19,575 |
| 2006-05-18 | Bienaime Jean Jacques (Chief Executive Officer) | Buy | 2,000 | 12.00 | 24,000 |
| 2006-05-08 | Bienaime Jean Jacques (Chief Executive Officer) | Buy | 1,000 | 12.78 | 12,778 |
| 2006-05-01 | Bienaime Jean Jacques (Chief Executive Officer) | Buy | 1,500 | 12.59 | 18,879 |
| 2006-04-03 | Bienaime Jean Jacques (Chief Executive Officer) | Buy | 1,500 | 13.34 | 20,010 |
| 2006-03-16 | Cooper Jeffrey H (Chief Financial Officer) | Sale | 12,500 | 14.85 | 185,625 |
| 2006-03-16 | Cooper Jeffrey H (Chief Financial Officer) | Option Ex | 12,500 | 8.10 | 101,250 |
| 2006-03-01 | Cooper Jeffrey H (Chief Financial Officer) | Sale | 15,500 | 13.25 | 205,375 |
| 2006-03-01 | Cooper Jeffrey H (Chief Financial Officer) | Option Ex | 15,500 | 5.64 | 87,420 |
| 2006-03-01 | Bienaime Jean Jacques (Chief Executive Officer) | Buy | 1,500 | 12.99 | 19,489 |
| 2006-02-27 | Cooper Jeffrey H (Chief Financial Officer) | Sale | 1,000 | 13.25 | 13,250 |
| 2006-02-27 | Cooper Jeffrey H (Chief Financial Officer) | Option Ex | 1,000 | 5.15 | 5,150 |
| 2006-02-27 | Lapalme Pierre (Director) | Buy | 3,500 | 12.98 | 45,440 |
| 2006-02-24 | Sager Erich (Director) | Sale | 11,500 | 12.64 | 145,360 |
| 2006-02-24 | Sager Erich (Director) | Option Ex | 11,500 | 7.00 | 80,500 |
| 2006-02-22 | Sager Erich (Director) | Sale | 1,000 | 12.20 | 12,200 |
| 2006-02-22 | Sager Erich (Director) | Option Ex | 1,000 | 7.00 | 7,000 |
| 2006-02-01 | Swiedler Stuart J (SVP, Clinical Affair) | Sale | 10,000 | 11.55 | 115,470 |
| 2006-02-01 | Swiedler Stuart J (SVP, Clinical Affair) | Option Ex | 10,000 | 4.00 | 40,000 |
| 2006-02-01 | Bienaime Jean Jacques (Chief Executive Officer) | Buy | 1,500 | 11.67 | 17,500 |
| 2006-01-27 | Sager Erich (Director) | Sale | 2,500 | 12.20 | 30,500 |
| 2006-01-27 | Sager Erich (Director) | Option Ex | 2,500 | 7.00 | 17,500 |
| 2006-01-04 | Kakkis Emil D (Chief Medical Officer) | Option Ex | 50,000 | 4.00 | 200,000 |
| 2006-01-03 | Bienaime Jean Jacques (Chief Executive Officer) | Buy | 1,500 | 10.79 | 16,177 |
| 2005-12-12 | Bienaime Jean Jacques (Chief Executive Officer) | Buy | 1,000 | 10.21 | 10,208 |
| 2005-12-05 | Sager Erich (Director) | Sale | 7,500 | 10.70 | 80,257 |
| 2005-12-01 | Sager Erich (Director) | Sale | 22,500 | 10.42 | 234,450 |
| 2005-12-01 | Starr Christopher M (SVP, Chief Scientifi) | Sale | 10,571 | 10.00 | 105,710 |
| 2005-12-01 | Bienaime Jean Jacques (Chief Executive Officer) | Buy | 1,500 | 9.96 | 14,937 |
| 2005-11-21 | Swiedler Stuart J (SVP, Clinical Affair) | Sale | 30,000 | 10.00 | 300,000 |
| 2005-11-21 | Starr Christopher M (SVP, Chief Scientifi) | Sale | 10,571 | 10.00 | 105,710 |
| 2005-11-01 | Bienaime Jean Jacques (Chief Executive Officer) | Buy | 1,500 | 8.37 | 12,554 |
| 2005-10-12 | Bienaime Jean Jacques (Chief Executive Officer) | Buy | 1,000 | 7.00 | 7,000 |
| 2005-10-06 | Bienaime Jean Jacques (Chief Executive Officer) | Buy | 500 | 8.00 | 4,000 |
| 2005-10-03 | Bienaime Jean Jacques (Chief Executive Officer) | Buy | 1,500 | 8.51 | 12,765 |
| 2005-09-01 | Bienaime Jean Jacques (Chief Executive Officer) | Buy | 4,500 | 8.57 | 38,587 |
Insider trading activities including stock purchases, stock sales, and option exercises
of BMRN listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Biomarin Pharmaceutical Inc (symbol BMRN,
CIK number 1048477) see
the Securities and Exchange Commission (SEC) website.